Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population‐based study

BACKGROUND: Patients with prostate cancer (PC) are at a high risk of developing secondary hematologic malignancies (SHMs) after radiation therapy (RT), while no study has assessed the relationship of different treatment modalities with the occurrence of SHMs after PC at early stage. This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Xiaofei, Zhou, Mingge, Yan, Hui, Chen, Xueqin, Wang, Yuetao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335824/
https://www.ncbi.nlm.nih.gov/pubmed/34189859
http://dx.doi.org/10.1002/cam4.4087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335824/
https://www.ncbi.nlm.nih.gov/pubmed/34189859
http://dx.doi.org/10.1002/cam4.4087

Ejemplares similares